Valuation: DexCom, Inc.

Market Cap 3.35TCr 2.89TCr 2.71TCr 2.47TCr 4.65TCr 3,20300Cr 4.71TCr 32TCr 12TCr 1,60400Cr 13TCr 12TCr 5,33700Cr P/E 2026 *
35.6x
P/E 2027 * 29.9x
Enterprise Value 3.27TCr 2.83TCr 2.65TCr 2.41TCr 4.54TCr 3,13000Cr 4.6TCr 31TCr 12TCr 1,56800Cr 12TCr 12TCr 5,21600Cr EV / Sales 2026 *
6.26x
EV / Sales 2027 * 5.59x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%-2.36% - - 3.39TCr
-0.79%+1.61%-16.23%+5.18% 19TCr
-0.73%+1.33%-2.60%+11.08% 12TCr
-0.41%-3.84%+6.73%+73.62% 5.99TCr
-0.02%+1.48%+34.53%+70.68% 5.6TCr
-0.71%+1.37%-7.07%-33.92% 5TCr
-1.10%+1.27%+9.65%-17.67% 3.39TCr
-2.41%+3.16% - - 3.14TCr
-1.49%-0.67%-7.44%+25.14% 2.48TCr
-0.80%-1.57%+40.78%-11.77% 2.46TCr
Average -0.77%+2.21%+7.29%+15.29% 6.55TCr
Weighted average by Cap. -0.71%+1.59%-0.53%+15.58%

Financials

2026 *2027 *
Net sales 523Cr 451.51Cr 423.59Cr 385.81Cr 725.44Cr 50TCr 735.5Cr 4.97TCr 1.95TCr 25TCr 1.96TCr 1.92TCr 83TCr 579.98Cr 500.69Cr 469.73Cr 427.84Cr 804.47Cr 55TCr 815.62Cr 5.51TCr 2.16TCr 28TCr 2.18TCr 2.13TCr 92TCr
Net income 97Cr 84Cr 79Cr 72Cr 135.15Cr 9.32TCr 137.02Cr 925.08Cr 362.51Cr 4.67TCr 365.81Cr 357.89Cr 16TCr 114.89Cr 99Cr 93Cr 85Cr 159.37Cr 11TCr 161.58Cr 1.09TCr 427.47Cr 5.5TCr 431.36Cr 422.02Cr 18TCr
Net Debt -76Cr -66Cr -62Cr -56Cr -105.58Cr -7.28TCr -107.04Cr -722.65Cr -283.18Cr -3.65TCr -285.76Cr -279.57Cr -12TCr -106.15Cr -92Cr -86Cr -78Cr -147.23Cr -10TCr -149.28Cr -1.01TCr -394.92Cr -5.08TCr -398.52Cr -389.89Cr -17TCr
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
88.76USD
Average target price
94.12USD
Spread / Average Target
+6.04%

Quarterly revenue - Rate of surprise